Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy

  1. Wei Li
  2. Xinqi Lou
  3. Yingjie Zha
  4. Yinyin Qin
  5. Jun Zha
  6. Lei Hong
  7. Zhanli Xie
  8. Shudi Yang
  9. Chen Wang
  10. Jianzhong An
  11. Zhenhao Zhang  Is a corresponding author
  12. Shigang Qiao  Is a corresponding author
  1. Soochow University, China
  2. Nanjing Medical University, China
  3. Suzhou Polytechnic Institute of Agriculture, China

Abstract

Myocardial fibrosis is the characteristic pathology of diabetes-induced cardiomyopathy. Therefore, an in-depth study of cardiac heterogeneity and cell-to-cell interactions can help elucidate the pathogenesis of diabetic myocardial fibrosis and identify treatment targets for the treatment of this disease. In this study, we investigated intercellular communication drivers of myocardial fibrosis in mouse heart with high-fat-diet (HFD)/streptozotocin (STZ)-induced diabetes at single-cell resolution. Intercellular and protein-protein interaction networks of fibroblasts and macrophages, endothelial cells, as well as fibroblasts and epicardial cells revealed critical changes in ligand-receptor interactions such as Pdgf(s)-Pdgfra and Efemp1-Egfr, which promote the development of a profibrotic microenvironment during the progression of and confirmed that the specific inhibition of the Pdgfra axis could significantly improve diabetic myocardial fibrosis. We also identified phenotypically distinct Hrchi and Postnhi fibroblast subpopulations associated with pathological extracellular matrix remodeling, of which the Hrchi fibroblasts were found to be the most profibrogenic under diabetic conditions. Finally, we validated the role of the Itgb1 hub gene mediated intercellular communication drivers of diabetic myocardial fibrosis in Hrchi fibroblasts, and confirmed the results through AAV9-mediated Itgb1 knockdown in the heart of diabetic mice. In summary, cardiac cell mapping provides novel insights into intercellular communication drivers involved in pathological extracellular matrix remodeling during diabetic myocardial fibrosis.

Data availability

All sequencing data that support this study is available from the Genome Sequence Archive in BIG Data Center (http://bigd.big.ac.cn/) with the accession code CRA007245. The ligand and receptor pairing dataset was obtained from Fantom5 (https://fantom.gsc.riken.jp/5/suppl/Ramilowski_et_al_2015/), as recently described (Ramilowski et al., 2015). Source data files are provided to support CT values of Col1a1 and Col3a1 used for Figure 3G-H. Source data files are provided to support CT values of Itgb1 used for Figure 6H. Source data files are provided to support Table 1 in Figure 3-Figure supplement 5.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Wei Li

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Xinqi Lou

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Yingjie Zha

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Yinyin Qin

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Jun Zha

    Faculty of Anesthesiology, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Lei Hong

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Zhanli Xie

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Shudi Yang

    Suzhou Polytechnic Institute of Agriculture, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Chen Wang

    Faculty of Anesthesiology, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Jianzhong An

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Zhenhao Zhang

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    For correspondence
    zhangzhh1@njmu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5659-6315
  12. Shigang Qiao

    Institute of Clinical Medicine Research, Nanjing Medical University, Suzhou, China
    For correspondence
    qiaos@njmu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.

Funding

Suzhou Science and Technology Development Plan (SKJY 2021038)

  • Shigang Qiao

Jiangsu Key Talent Youth Awards in Medicine (QNRC2016219)

  • Shigang Qiao

Gusu Health Youth Talent Awards (GSWS2019092)

  • Shigang Qiao

Gusu Health Talent Program (GSWS2021068)

  • Zhenhao Zhang

Suzhou New District Science and Technology Project (2020Z007)

  • Zhenhao Zhang

General Program of Basic Science in Jiangsu Higher Education Institutions (21KJB350017)

  • Shudi Yang

the Core Medical Science Subjects in Suzhou (SZXK202131)

  • Shudi Yang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was approved by the Ethics Committee of Soochow University and Suzhou Science & Technology Town Hospital, Gusu School, Nanjing Medical University. Reference number: 2022-B23. All mouse were treated in accordance with the National Institutes of Health's Guidelines for the Care and Use of Experimental Animals (NIH publications No. 80-23, revised 1996).

Copyright

© 2023, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,848
    views
  • 693
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wei Li
  2. Xinqi Lou
  3. Yingjie Zha
  4. Yinyin Qin
  5. Jun Zha
  6. Lei Hong
  7. Zhanli Xie
  8. Shudi Yang
  9. Chen Wang
  10. Jianzhong An
  11. Zhenhao Zhang
  12. Shigang Qiao
(2023)
Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy
eLife 12:e80479.
https://doi.org/10.7554/eLife.80479

Share this article

https://doi.org/10.7554/eLife.80479

Further reading

    1. Cancer Biology
    2. Cell Biology
    Xiangning Bu, Nathanael Ashby ... Inhee Chung
    Research Article

    Cell crowding is a common microenvironmental factor influencing various disease processes, but its role in promoting cell invasiveness remains unclear. This study investigates the biomechanical changes induced by cell crowding, focusing on pro-invasive cell volume reduction in ductal carcinoma in situ (DCIS). Crowding specifically enhanced invasiveness in high-grade DCIS cells through significant volume reduction compared to hyperplasia-mimicking or normal cells. Mass spectrometry revealed that crowding selectively relocated ion channels, including TRPV4, to the plasma membrane in high-grade DCIS cells. TRPV4 inhibition triggered by crowding decreased intracellular calcium levels, reduced cell volume, and increased invasion and motility. During this process, TRPV4 membrane relocation primed the channel for later activation, compensating for calcium loss. Analyses of patient-derived breast cancer tissues confirmed that plasma membrane-associated TRPV4 is specific to high-grade DCIS and indicates the presence of a pro-invasive cell volume reduction mechanotransduction pathway. Hyperosmotic conditions and pharmacologic TRPV4 inhibition mimicked crowding-induced effects, while TRPV4 activation reversed them. Silencing TRPV4 diminished mechanotransduction in high-grade DCIS cells, reducing calcium depletion, volume reduction, and motility. This study uncovers a novel pro-invasive mechanotransduction pathway driven by cell crowding and identifies TRPV4 as a potential biomarker for predicting invasion risk in DCIS patients.

    1. Cell Biology
    Dan Wu, Venkateswararao Eeda ... Weidong Wang
    Research Article

    Overnutrition engenders the expansion of adipose tissue and the accumulation of immune cells, in particular, macrophages, in the adipose tissue, leading to chronic low-grade inflammation and insulin resistance. In obesity, several proinflammatory subpopulations of adipose tissue macrophages (ATMs) identified hitherto include the conventional ‘M1-like’ CD11C-expressing ATM and the newly discovered metabolically activated CD9-expressing ATM; however, the relationship among ATM subpopulations is unclear. The ER stress sensor inositol-requiring enzyme 1α (IRE1α) is activated in the adipocytes and immune cells under obesity. It is unknown whether targeting IRE1α is capable of reversing insulin resistance and obesity and modulating the metabolically activated ATMs. We report that pharmacological inhibition of IRE1α RNase significantly ameliorates insulin resistance and glucose intolerance in male mice with diet-induced obesity. IRE1α inhibition also increases thermogenesis and energy expenditure, and hence protects against high fat diet-induced obesity. Our study shows that the ‘M1-like’ CD11c+ ATMs are largely overlapping with but yet non-identical to CD9+ ATMs in obese white adipose tissue. Notably, IRE1α inhibition diminishes the accumulation of obesity-induced metabolically activated ATMs and ‘M1-like’ ATMs, resulting in the curtailment of adipose inflammation and ensuing reactivation of thermogenesis, without augmentation of the alternatively activated M2 macrophage population. Our findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity.